Matrix metalloproteinase-2 stimulates collagen-I expression through phosphorylation of focal adhesion kinase in rat cardiac fibroblasts. Am J Physiol Cell Physiol 303: C947-C953, 2012. First published August 22, 2012; doi:10.1152/ajpcell.00401.2011.-Collagen-I is thought to be the main component of the extracellular matrix in cardiac fibrosis, the accumulation of which occurs with excessive activation of matrix metalloproteinase-2 (MMP-2). MMP-2 degrades the extracellular matrix; however, the relative importance of MMP-2 to collagen-I synthesis in cardiac fibroblasts remains unclear. We investigated whether extracellular activation of MMP-2 regulates collagen-I synthesis and phosphorylation of focal adhesion kinase (FAK) in rat cardiac fibroblasts. Primary cultures of rat cardiac fibroblasts were incubated with purified active MMP-2 to determine whether extracellular MMP-2 affects collagen-I synthesis and FAK phosphorylation in cardiac fibroblasts. Exogenous MMP-2 significantly stimulated FAK (Tyr397) phosphorylation and induced collagen-I expression in a time-dependent manner. Simultaneous treatment with the FAK inhibitor PF573228 abolished exogenous MMP-2-enhanced FAK (Tyr397) phosphorylation and collagen-I expression. Cells were then stimulated with norepinephrine (NE) to investigate whether endogenous MMP-2 could also induce collagen-I expression through FAK (Tyr397) phosphorylation. NE-stimulated endogenous MMP-2 activation in conditioned medium was significantly attenuated by simultaneous treatment with the MMP inhibitor PD166793. Similarly, NE-induced FAK (Tyr397) phosphorylation and collagen-I expression were significantly inhibited by simultaneous treatment with PD166793 or PF573228. Furthermore, MMP-2 knockdown induced by small interfering RNA (siRNA) significantly abolished endogenous MMP-2 expression and activation. MMP-2 siRNA significantly abolished NE-induced FAK (Tyr397) phosphorylation and collagen-I expression. These findings suggest that the extracellular activation of MMP-2 accelerated collagen-I synthesis in rat cardiac fibroblasts and that FAK phosphorylation (Tyr397) plays a pivotal role in MMP-2-stimulated collagen-I synthesis.
MANY FORMS OF HEART DISEASE are associated with cardiac fibrosis resulting from an imbalance in the synthesis and degradation of the extracellular matrix (ECM). Among various ECM fragments related to cardiac fibrosis, collagen-I is thought to be the main component of the ECM in a diseased heart. For example, the sympathetic nervous system is activated in patients with various heart diseases (12, 24, 39) , which accelerated collagen accumulation and associated with an increased risk for heart failure (3, 25) . Indeed, several animal studies (2, 17) have reported that chronic sympathetic activation induces cardiac fibrosis, including collagen-I accumulation in the ventricular myocardium.
Matrix metalloproteinases (MMPs) are Ca 2ϩ -and Zn 2ϩ -dependent endoproteinases that are classified into interstitial collagenases, stromelysins, and gelatinases based on substrate specificity (6, 34) . MMP-2, which is a gelatinase, has the capacity to degrade ECM molecules, including gelatins, fibronectin, and collagen-I (6, 29) . Although MMPs degrade ECM proteins, activation of MMP-2 occurs concomitantly with cardiac fibrosis in a failing heart (22, 25, 32, 34 -36) . Accordingly, catecholamines have emerged as a pivotal mediator of collagen fragment synthesis in failing hearts, which is accompanied by increased MMP expression (2, 14, 23, 30) . Several animal studies (2, 9, 17, 28) have reported that adrenergic receptor signals stimulate collagen-I synthesis and MMP-2 expression/activation in ventricular myocardium. In contrast, in vivo experiments have shown that inhibiting MMP-2 remarkably improves cardiac fibrosis and left ventricular collagen-I mRNA expression in rats with heart failure (4, 17, 21) , suggesting a critical role for this enzyme in cardiac fibrosis. Hence, we hypothesized that excess expression/activation of MMP-2 could accelerate collagen-I synthesis. However, it remains unknown whether extracellular activation of MMP-2 regulates collagen-I synthesis in cardiac fibroblasts.
Integrins are an important family of transmembrane adhesion molecules and serve as adhesion receptors for ECM proteins (13) . Integrin leads to the formation of focal adhesions and transduces biochemical signals into the cell via adaptor molecules such as focal adhesion kinase (FAK) by autophosphorylation of tyrosine 397 (13, 27, 40) . These complexes are also involved in the sensing and processing of external mechanical stimuli, such as substrate stretching (10, 37, 40) . Additionally, FAK mediates various cellular functions, including myocyte hypertrophy, differentiation, apoptosis, and ECM synthesis (10, 15, 27 ). Thus we speculated that focal adhesion is a candidate for mediating extracellular MMP-2 activation signaling from the ECM into cardiac fibroblasts. However, the involvement of FAK in response to extracellular MMP-2-mediated collagen-I synthesis, regardless of mechanical stress, remains uncertain in cardiac fibroblasts.
Here, our purpose of the present study was to investigate whether extracellular activation of MMP-2 regulates collagen-I synthesis through FAK phosphorylation in rat cardiac fibroblasts.
MATERIALS AND METHODS
This study followed the Guidelines for Institutional Laboratory Animal Care and Use of the School of Veterinary Medicine at Kitasato University, Japan (approval no. 10 -023). Four-week-old male Wistar Kyoto rats (n ϭ 18) were obtained from Charles River (Yokohama, Japan).
Chemicals. PF573228 and (Ϫ)norepinephrine (NE) were purchased from Sigma-Aldrich (St. Louis, MO). PD166793 was purchased from Calbiochem (La Jolla, CA). MMP-2 was purchased from Abcam (Tokyo, Japan). DMSO was used to dissolve PD166793 and PF573228; the final concentration per assay was Ͻ 0.1%. DMEM (Sigma-Aldrich) was used to dissolve NE. Finally, each chemical was mixed with serum-free DMEM immediately before treatment.
Cells. Primary cultures of cardiac fibroblasts were established using techniques described previously (18) . Briefly, the left ventricle was minced and placed in a collagenase/protease digestion solution (Wako Pure Chemical, Osaka, Japan) for 60 min. After centrifugation, the cells were rinsed with serum-free DMEM, and the cell suspension was transferred to cell culture flasks. The cells were incubated with DMEM supplemented with 10% FBS and 1% antibiotic-antimycotic solution (penicillin, streptomycin, and amphotericin B; Sigma-Aldrich) under standard cell culture conditions (37°C; 5% CO2). After two or three passages (at 80% confluency), the cells were plated in six-well plates at a density of 2.0 -3.0 ϫ 10 4 cells/well. After a 24-h incubation, the medium was replaced with serum-free DMEM for 24 h, and then the cells were used in the experiments. All studies were performed in serum free-DMEM.
Fibroblasts were easily characterized due to their spindle-shaped morphology. The composition of the cultures was Ͼ95% cardiac fibroblasts, as they immunostained positive for vimentin and negative for desmin and smooth muscle ␣-actin (18). Western blot analysis. Primary cultured cells were harvested in lysis buffer, the protein extracts (6 g) were separated on 10% SDS-polyacrylamide gels, and the proteins were transferred to PVDF membranes (Immobilon RP; Millipore, Bedford, MA). The membranes were incubated with primary antibodies at the following dilutions: anti-collagen-I, 1:500 (Rockland Immunochemicals, Gilbertsville, PA); and anti-phospho-FAK (Tyr397) and anti-FAK, each 1:1,000 (both from Cell Signaling Technology, Danvers, MA); anti-MMP-2, 1:2,000 (Abcam); and anti-␤-actin, 1:1,000 (Santa Cruz Biotechnology). The membranes were subsequently incubated with horseradish peroxidase-labeled secondary antibody (Santa Cruz Biotechnology) at a dilution of 1:10,000 -20,000. The proteins were visualized with peracid and luminol (ECL Western blotting detection reagents; GE Healthcare, Piscataway, NJ). Protein expression was quantified using Alpha Ease FC (Alpha Innotech, San Leandro, CA).
MMP zymography. Conditioned media from fibroblasts that had been incubated in serum-free medium containing antibiotics for 24 h were mixed with a one-fourth volume of 4ϫ sample buffer (16) . Proteins were obtained by trichloroacetic acid precipitation for protein measurement. The protein (50 ng) was separated on 10% SDS-polyacrylamide gels containing 0.6% gelatin. The gels were then washed twice with extraction buffer for 30 min and rinsed with deionized H 2O. The gels were incubated overnight at 37°C in incubation buffer before being stained with Coomassie staining solution for 2 h and then destained in distilled deionized H 2O. An MMP marker (Gelatin Zymo MMP Marker; Life Laboratory, Yamagata, Japan) was used as the control. Gelatinolytic bands were quantified as described above.
Real time-PCR. Transcription of the genes encoding MMP-2 and GAPDH in the cultured cells was determined by real-time PCR. After 48 h incubation, 0.6 ml TRIzol (Invitrogen, Carlsbad, CA) were dispensed to each culture dish on ice. DNA-free total RNA was extracted from the cells, according to the manufacturer's recommendations, and used to prepare cDNA by reverse transcription (multiscribe reverse transcription kit; Applied Biosystems) with random primers at 37°C for 2 h. We used a StepOnePlus Real-Time PCR system (Applied Biosystems) to amplify and quantify cDNA. SYBR Green PCR Master Mix (Applied Biosystems) was used in all reactions, and regular melting curves were confirmed. Relative mRNA levels were calculated using the ⌬⌬C t method, based on GAPDH mRNA expression. The primer sequences of the MMP-2 and GAPDH were as follows: MMP-2 forward primer: 5=-TTATTTGGCGGACAGT-GACA-3=; reverse primer: 5=-ACACGGCATCAATCTTTTCC-3=; and GAPDH forward primer: 5=-GGCATTGCTCTCAATGACAA-3=; reverse primer: 5=-ATGTAGGCCATGAGGTCCAC-3=.
MMP-2 small interfering RNA. Transfection of cardiac fibroblasts with small interfering RNA (siRNA) was performed as previously described (20) . The silencer predesigned siRNA against MMP-2 (s135546; Life Technologies, Carlsbad, CA) was synthesized according to rat-specific sequences. A nontargeting scrambled siRNA (control siRNA) was used as a negative control (Life Technologies). Cardiac fibroblasts were transfected with Lipofectamine RNAiMAX (Life Technologies) in suspension with MMP-2 siRNA.
Statistical analysis. All numerical data are expressed as means Ϯ SE. Protein and mRNA expression of MMP-2 with or without NE was analyzed by Student's t-tests. Other statistical analyses were performed with a one-way ANOVA followed by Tukey's multiple comparison test. Differences were considered significant at P Ͻ 0.05.
RESULTS

Exogenous MMP-2 increases FAK (Tyr397) phosphorylation and collagen-I expression.
Although MMPs degrade ECM proteins, MMP-2 activation was paradoxically concomitant with cardiac fibrosis. Cells were incubated with or without purified active 10 Ϫ9 M MMP-2 (27) to address whether the activation of extracellular MMP-2 affected collagen-I synthesis and focal adhesion in cardiac fibroblasts. Compared with the vehicle control, active MMP-2 significantly phosphorylated FAK (Tyr397; Fig. 1A ). In addition, active MMP-2 significantly increased collagen-I expression in a time-dependent manner (Fig. 1B) .
Inhibition of FAK phosphorylation attenuates exogenous MMP-2-induced collagen-I expression.
To address whether exogenous MMP-2-stimulated FAK (Tyr397) phosphorylation affected collagen-I synthesis in cardiac fibroblasts, cells were incubated with or without 10 Ϫ6 M PF573228, a specific inhibitor of FAK activity. Although exogenous MMP-2 stimulated both FAK phosphorylation and collagen-I expression, simultaneous treatment of PF573228 with MMP-2 maintained FAK phosphorylation and collagen-I expression at a basal level (Fig. 2, A and B) . Similarly, collagen-I expression in the culture supernatant was elevated by exogenous MMP-2, but simultaneous treatment of PF573228 with MMP-2 maintained collagen-I expression at a basal level (Fig. 2C) . 
Endogenously induced MMP-2 increases collagen-I expression through FAK (Tyr397) phosphorylation.
As catecholamines evoke endogenous MMP-2 expression/activation and collagen-I synthesis in fibroblasts (2, 19, 28, 38), we stimulated the cardiac fibroblasts with 10 Ϫ6 M NE to induce the endogenous expression of MMP-2. As shown in Fig. 3 , MMP-2 mRNA and protein expression levels were significantly higher in the NE-treated cells compared with that in vehicle-treated cells. The endogenous MMP-2 activity that was induced by NE in the culture supernatant was almost three times higher than in PD166793-treated cells, and simultaneous treatment of PD166793 with NE maintained endogenous MMP-2 activity at a basal level (Fig. 4) . Thus we found that NE induced endogenous MMP-2 activation, and 10 Ϫ4 M PD166793, which is a specific inhibitor of MMP activity that blocks zinc-binding sites, inhibited the increased endogenous MMP-2 activity induced by NE. Next, we investigated whether endogenously induced MMP-2 stimulates FAK phosphorylation and collagen-I synthesis in cardiac fibroblasts by incubating cells with NE and/or PD166793. Although NE significantly enhanced FAK (Tyr397) phosphorylation and collagen-I expression, levels were significantly attenuated by simultaneous treatment with PD166793 (Fig. 5, A and B) . Moreover, simultaneous treatment of PF573228 with NE significantly attenuated both NE-induced FAK (Tyr397) phosphorylation and collagen-I expression (Fig. 6,  A and B) . Similarly, collagen-I expression in the culture supernatant was elevated by NE, but simultaneous treatment of PF573228 with NE maintained collagen-I expression at a basal level (Fig. 6C) .
MMP-2 siRNA abolishes NE-induced FAK (Tyr397) phosphorylation and collagen-I expression.
We used siRNA to knockdown MMP-2 to determine the role of endogenously induced-MMP-2 in collagen-I expression by cardiac fibroblasts. After transfection with 50 nM MMP-2 siRNA for 24 h, both MMP-2 expression and activity were almost abolished, even in NE-treated cells (Fig. 7, A and B) . Furthermore, MMP-2 knockdown induced by siRNA attenuated NE-stimulated FAK (Tyr397) phosphorylation and collagen-I expression (Fig. 8, A and B) . Finally, the collagen-I expression in the culture supernatant was elevated by NE, but MMP-2 knockdown maintained NE-stimulated collagen-I expression at a basal level (Fig. 8C) .
DISCUSSION
Cardiac fibrosis is associated with collagen accumulation resulting from an imbalance in the synthesis and degradation of the ECM. Further, collagen-I is thought to be the main component of the ECM in the diseased heart. MMPs play a significant role in ECM turnover during pathophysiological processes (11, 33) . Although MMPs degrade ECM proteins, MMP-2 activation is concomitant with cardiac fibrosis in several heart diseases (25, 32, 34, 35) . Accordingly, catecholamines induce the synthesis of collagen fragments in a failing heart, which is accompanied by MMP-2 expression/ activation (2, 27) . Indeed, adrenergic receptor stimulation induces collagen-I expression and MMP-2 expression/activation in fibroblasts (1, 5, 19, 31) . These studies reinforced our findings showing that NE stimulated MMP-2 expression/activation concomitant with increased collagen-I expression. In contrast, pharmacological inhibition of MMP activity attenuates the ventricular remodeling process in animal models of heart disease (2, 4, 17, 21). Indeed, the broad spectrum MMP inhibitor doxycycline attenuates isoproterenol-induced ventricular fibrosis and collagen expression (17) . Similarly, inhibiting MMP-2 reduces myocardial collagen expression in rats with hypertensive heart failure (21, 26) . These results lead to the speculation that extracellular activation of MMP-2 mediates signaling from the ECM into the cell and accelerates collagen-I synthesis in cardiac fibroblasts. However, little is known regarding the functional role of MMP-2 and whether extracellular activation of MMP-2 is related to collagen-I synthesis in cardiac fibroblasts. A novel finding of this study was the demonstration that exogenously active MMP-2 significantly increased collagen-I expression in a time-dependent manner. Although NE induced endogenous MMP-2 expression/activation, NE-induced collagen-I expression was completely attenuated by inhibiting extracellular MMP-2 activation and MMP-2 knockdown. These results suggest that extracellular activation of MMP-2 plays an essential role in regulating collagen-I expression in rat cardiac fibroblasts.
Focal adhesion is one of the major functional units mediating cell-substrate interactions, and matrix-derived mechanical stimuli can be transmitted through the direct or indirect interaction of integrins functioning as mechanoreceptors with associated signaling molecules such as FAK (13, 40) . Activation of FAK is regulated by integrin-ECM interactions, and integrin ligation and clustering activate FAK by autophosphorylation of tyrosine 397. The degree of FAK phosphorylation appears to be supported by the strength of mechanical stress. Indeed, the contraction of collagen-I matrixes induces FAK dephosphorylation in fibroblasts (40) , whereas cyclic stretch induces FAK phosphorylation in cardiac fibroblasts and myocytes (10, 37) . Little is known regarding the effects of MMP-2 on cultured cells (27) ; however, it remains unknown whether extracellular activation of MMP-2 regulates FAK phosphorylation in cardiac fibroblasts. Our results show that exogenous active MMP-2 phosphorylated FAK (Tyr397). Similarly, NE induced endogenous activation of MMP-2 with concomitant FAK phosphorylation (Tyr397). In contrast, simultaneous treatment with the MMP inhibitor PD166793 and MMP-2 knockdown significantly attenuated extracellular MMP-2 activation and FAK (Tyr397) phosphorylation. This is the first study to demonstrate that extracellular activation of MMP-2, regardless of mechanical stress, is profoundly related to FAK phosphorylation (Tyr397) in rat cardiac fibroblasts.
FAK plays an important role in various cellular activities and the survival of cardiac myocytes and fibroblasts (10, 15, 27, 28) . Although dephosphorylated FAK promotes apoptosis in fibroblasts in response to mechanical stress (40), phosphorylated FAK also promotes differentiation into myofibroblast and collagen synthesis in cardiac fibroblasts (10) . Furthermore, in vivo and in vitro evidence supports the notion that FAK phosphorylation mediates cardiac fibrosis and collagen-I expression (8, 10) . Although cyclic stretch induces FAK phosphorylation and collagen-I synthesis in cardiac fibroblasts, FAK knockdown markedly reduces stretch-induced collagen-I expression (10) . However, the involvement of FAK in the response to extracellular MMP-2-mediated collagen-I synthesis in cardiac fibroblasts remains uncertain. In the present study, exogenous active MMP-2-stimulated collagen-I expression was completely attenuated by simultaneous treatment with a specific FAK activity inhibitor. Similarly, NE induced increased endogenous expression and activation of MMP-2 was concomitant with the increase in FAK (Tyr397) phosphorylation and collagen-I expression. In contrast, inhibiting FAK (Tyr397) phosphorylation significantly attenuated NE-induced collagen-I expression. These results indicate that extracellular MMP-2-stimulated FAK phosphorylation plays a pivotal role in the regulation of collagen-I synthesis.
Limitations. Because NE has both ␣-adrenergic receptor and ␤-adrenergic receptor effects, the receptor actions that mediate MMP-2 induction must be identified. FAK phosphorylation derived by MMP-2 can be mediated through direct or indirect interaction of integrin and/or the ECM. It is possible that active MMP-2 cleaves an ECM protein, exposing an Arg-Gly-Asp peptide, or that there is a direct interaction between MMP-2 and integrin. It has already been reported that MMPs cleave heparin-binding epidermal growth factor (18a, 41). Therefore, a third possible mechanism for FAK activation by MMP-2 could be cleavage of a tethered agonist, such as heparinbinding epidermal growth factor. However, the possible mechanisms by which extracellular MMP-2 modulates the integrin-ECM interaction are still unclear. Therefore, future studies that identify the mechanisms by which extracellular activation of MMP-2 modulates the integrin-ECM interaction are warranted.
Conclusion. We investigated whether extracellular activation of MMP-2 regulates collagen-I synthesis through FAK phosphorylation in rat cardiac fibroblasts. We provide three new major findings: 1) exogenous active MMP-2 stimulated FAK (Tyr397) phosphorylation and collagen-I expression; 2) NE increased endogenous MMP-2, whereas both MMP inhibition and MMP-2 knockdown inhibited NE-induced FAK (Tyr397) phosphorylation and collagen-I expression; and 3) inhibition of FAK activity attenuated exogenous and endogenous MMP-2-induced collagen-I expression. These results suggest that excess activation of extracellular MMP-2 stimulates collagen-I synthesis through FAK (Tyr397) phosphorylation in rat cardiac fibroblasts. 
